Adopted Trials - lymphoma (Hodgkins)
Acronym: VEPEMB/SHIELD
Full Title
A phase II study of vinblastine, endoxana (cyclophosphamide), procarbazine, prednisolone, etoposide, mitoxantrone and bleomycin in patients with Hodgkin's lymphoma aged over 60 years.
Treatment: chemotherapy
Phase: II
Chief Investigator: Prof. Stephen John Proctor
Type of trial: Early Phase
Website: http://www.shieldstudy.co.uk/
Acronym: ABVD
Full Title
A Randomised Phase III Trial to assess response adapted therapy using FDG-PET imaging in patients with newly diagnosed, advanced Hodgkin Lymphoma
Treatment:
Phase: I
Chief Investigator:
Type of trial:
Website:
